Preisträger 2009 – heute

Hier finden Sie die aktuelle Liste der HEMMI-Forschungspreisgewinner von 2009 bis zum heutigen Zeitpunkt

Liste der Preisträger

2025 - Dr. med. Dr. phil. Salome Hosch PHD - 12'500.-

Titel
Molecular tissue-based precision diagnostics of infectious diseases

2025 - Dr. Baptiste Hamelin PHD - 12'500.-

Titel
Molecular tissue-based precision diagnostics of infectious diseases

2025 - Dr. med. Tibor Andrea Zwimpfer - 25'000.-

Titel
RB1 loss and depth of homologous recombination deficiency as predictors of outcomes with olaparib and bevacizumab in first-line maintenance of ovarian cancer: a PAOLA-1 substudy

2024 - Dr. med. Franziska Geissler - 25'000.-

Titel
Silencing PARP inhibitor resistance – Exploiting BRCA1 and RAD51C methylation stability to improve PARP inhibitor responses in high-grade serous ovarian carcinomas

2024 - Prof. Dr. med. Katharina Timper - 25'000.-

Titel
Odour-based volatile small molecules for metabolism control – The OLFAMED project

2023 - Eliane Rohner MD MSc - 25'000.-

Titel
DNA methylation tests for the detection of persistent precancerous cervical lesions in women living with HIV in Zimbabwe

2023 - Dr. med. Cihan Atila - 25'000.-

Titel
Oxytocin Substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial

2022 - Charly Jehanno, PhD - 25'000.-

Titel
NNMT evokes epigenetic rewiring and promotes metastatic colonization in breastcancer.

2022 - Christine Schneider, MD - 25'000.-

Titel
Early pulmonary dysfunction in paediatric cancer patients.

2021 - Dr. med. Adriana Peric - 25'000.-

Titel
Einfluss von Microbiota auf die Fertilität.

2021 - Dr. med. Zina-Mary Manjaly - 25'000.-

Titel
Mechanism of Fatigue in Multiple Sclerosis-Investigation with fMRI.

2020 - Dr. sc. nat. Miro Emanuel Räber - 30'000.-

Titel
Interleukin – 2 – modulated B cellhomeostasis in systemic lupuserythematosus.

2020 - PD Dr. med., MD, PhD Kirsten Diana Mertz - 10'000.-

Titel
Two distinct immunopathological profilesin lungs of lethal COVID-19.

2019 - PD Dr. phil. nat. Ursula Amstutz - 30'000.-

Titel
Nachweis von Spender-spezifischer zellfreier DNA im Blut und Urin als Hinweis auf Schädigung im Spenderorgan.

2019 - Dr. med. Alain Amstutz, MD - 10'000.-

Titel
GET ON in Lesotho mit den Hoseng und Vibra Studien.

2018 - Professor Dr. med. Mike Recher - 30'000.-

Titel
Detection of Sp110 by Flow Cytometryand Application to Screening Patients for Veno-occlusive Disease withImmunodeficiency.
(J.Clin.Immunol. (2017) 37:707 – 714)

2017 - PD Dr. med. Albina Nowak-Wilhelm - 20'000.-

Titel
Effect of intravenous Iron versus Placebo on cerebral Dopamine Receptor Density in non anemic premenopausal Womenwith low. Ferritin Levels and Fatigue.

2016 - Dr. med. Heike Gudat - 15'000.-

Titel
Palliative oncology and non-oncology Patients wish to die

2016 - Professor Dr. med. Heiner Bucher - 15'000.-

Titel
Chronic Hepatitis B an C co-Infection, risk for the development of NON-Hodgkin Lymphoma in HIV-infectedpatients.

2015 - PD Dr. med. U. Möhrlen - 15'000.-

Titel
Fetal Surgery for Myelomeningocele: A Critical Appraisal

2015 - Dr. med. Ilario Fulco - 15'000.-

Titel
Engineered autologous cartilage tissue for nasal reconstruction after tumourresection: An observational first-in-human trial.
(Lancet 2014;384:337 – 346)
Fetal Surgery for Myelomeningocele: ACritical Appraisal

2013 - Dr. med. Christian Schürch - 20'000.-

Titel
CD27 as a Novel Therapeutic Target in Acute Myeloid Leukemia

2012 - Professor Dr. med. Reto Krapf - 20'000.-

Titel
Effect of Potassium Citrate on Bone Density, Microarchitecture and Fracture Risk in Healthy older Adults withoutOsteoporosis : A Randomized ControlledTrial

2011 - Dr. med. P. Krayenbühl - 20'000.-

Titel
Eisenmangel ohne Anämie

2010 - PD Dr. med. Andreas Lohri / PD Dr. med.Flavio Forrer - 20'000.-

Titel
Neuartige Radio-Immuntherapie